| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.7M | — | -4.9% |
| Cost of Revenue | $20.5M | — | +25.3% |
| R&D Expense | $14.4M | — | +14.6% |
| SG&A Expense | $64.9M | — | +10.7% |
| Operating Income | -$18.4M | — | +34.1% |
| Income Tax | $109K | — | +125.8% |
| Net Income | -$14.5M | — | +43.8% |
| EPS (Basic) | -$0.49 | — | +45.6% |
| EPS (Diluted) | -$0.49 | — | +45.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $63.8M | -45.4% | -28.9% |
| Short-term Investments | $197.9M | +8.3% | +6.7% |
| Accounts Receivable | $42.3M | -2.6% | -25.0% |
| Inventory | $10.5M | +2.0% | +52.7% |
| Current Assets | $328.9M | -8.9% | -5.9% |
| Total Assets | $547.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.1M | — | -266.6% |
| Capital Expenditures | $12.5M | — | +162.8% |
| Investing Cash Flow | -$25.8M | — | -15.0% |
| Financing Cash Flow | -$5.0M | — | -224.1% |
| Free Cash Flow | -$34.6M | — | -220.9% |
| +9.2% |
| Current Liabilities | $48.8M | -29.0% | +30.8% |
| Long-term Debt | $10.1M | +0.1% | +0.3% |
| Total Liabilities | $86.4M | -19.8% | +40.7% |
| Stockholders' Equity | $461.4M | -2.0% | +4.8% |